share_log

HC Wainwright & Co.:重申BioXcel Therapeutics(BTAI.US)评级,由买入调整至买入评级, 目标价10.00美元。

Zhitong Finance ·  Apr 23 06:36

HC Wainwright & Co.:重申BioXcel Therapeutics(BTAI.US)评级,由买入调整至买入评级, 目标价10.00美元。

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment